ArticleAnnals of surgical oncology2024

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.

Deesje Doppenberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.